ViewMind developers digital biomarkers for Evidence Based Disease Management of Neurodegenerative Disorders. The solution comprises of visual stimuli, eye tracking and artificial intelligence and delivers a breakthrough in sensitivity and specificity. ViewMind’s digital biomarker’s are reliable, non-invasive, affordable, accessible and work on patients independent of culture, age and education.